Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$47.15 +0.18 (+0.38%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Return on Sales [ROS] (2010 - 2026)

Updated

Rigel Pharmaceuticals (RIGL) reported Return on Sales [ROS] of 29.95% for Q2 2026, down 30.14 percentage points from 60.09% a year earlier but up 9.75 percentage points from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Rigel Pharmaceuticals' Return on Sales [ROS] came in at 31.45%, down 7.59 percentage points year-over-year; for FY2025, it was 42.63%, up 29.14 percentage points from FY2024.

  • Return on Sales [ROS] has increased for three consecutive years, with a five-year change of +69.31 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at 13.49% in FY2024 (+31.03 pp), -17.53% in FY2023 (+28.67 pp), -46.20% in FY2022 (-37.83 pp) and -8.37% in FY2021 (+18.30 pp).
  • Five-year quarterly Return on Sales [ROS] spans a low of -156.92% in Q1 2022 and a high of 60.09% in Q2 2025.
  • Year over year, Return on Sales [ROS] gained in six of the last eight quarters, with an average year-over-year change of +19.63 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q4 2022 (a gain of 109.00 percentage points); the low point was Q1 2022 (a drop of 208.46 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 20.21% (Q1 2026), 33.19% (Q4 2025) and 40.91% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Rigel Pharmaceuticals 880.76 Mn 346.64 Mn 70.18 Mn 29.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.95%
Mar 31, 2026 20.21%
Dec 31, 2025 33.19%
Sep 30, 2025 40.91%
Jun 30, 2025 60.09%
Mar 31, 2025 23.95%
Dec 31, 2024 28.92%
Sep 30, 2024 25.41%
Jun 30, 2024 1.21%
Mar 31, 2024 -23.59%
Dec 31, 2023 5.49%
Sep 30, 2023 -15.87%
Jun 30, 2023 -19.59%
Mar 31, 2023 -48.81%
Dec 31, 2022 4.05%
Sep 30, 2022 -82.12%
Jun 30, 2022 -43.48%
Mar 31, 2022 -156.92%
Dec 31, 2021 -104.94%
Sep 30, 2021 -91.84%
API Access

Rigel Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RIGL&period=max&api_key=YOUR_API_KEY